Physician profile

Emmanuel George Gage

Interventional Pain Medicine · Brunswick, GA

NPI 1720213093

$601,779.60

in general payments reported to CMS, 2019-2025

36 companies · $153K in 2025

The $153K reported for 2025 was more than what 99% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).

See the full distribution for Interventional Pain Medicine

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program$171,962.50
Consulting Fee$118,550.00
Travel and Lodging$29,099.65
Food and Beverage$17,660.97
Education$1,500.00

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Boston Scientific Corporation $417,419.63 2019-2025 Wavewriter Alpha Prime 16, Superion Indirect Decompression System, General - Therapies
Si-Bone, INC. $101,967.79 2024-2025
Vertos Medical, INC. $50,272.94 2020-2024 Mild Device Kit
Vertiflex, INC. $18,603.27 2019
Alevio, LLC $5,784.59 2022-2023 Sicure Sacroiliac Joint Fusion System
Painteq LLC $2,435.87 2021-2024 Painteq
Genesys Orthopedics Systems, L.L.C. $2,339.70 2021-2022
Intelivation Technologies, LLC $500.00 2022
Abbott Laboratories $489.74 2022
Medtronic, INC. $469.83 2021-2025 Kyphon Express II Kyphopak Tray
Stryker Corporation $344.31 2019-2025 Spinejack, Mild Device Kit
Merit Medical Systems INC $196.44 2024 Star Tumor Ablation System, Stabilit System
Collegium Pharmaceutical, INC. $119.72 2022-2023 Xtampza
Relievant Medsystems, INC. $110.43 2021-2023 Intracept
Curonix LLC $94.33 2023-2024 Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A
Show all 36 companies
CompanyGeneral paymentsYearsTop products
Amgen INC. $67.14 2023-2024 Evenity, Prolia
Scilex Pharmaceuticals INC. $56.50 2021
Abbvie INC. $49.97 2023-2024
Spr Therapeutics, INC $49.38 2022-2025 Sprint Pns System
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $43.39 2022
Nalu Medical, INC. $39.44 2021-2024 Nalu Neurostimulation System
Medtronic USA, INC. $38.53 2020
Nevro Corp. $31.43 2023-2024 Senza
Saluda Medical Americas, INC. $25.80 2023 Evoke Scs
Heron Therapeutics, INC. $24.95 2022
Vertex Pharmaceuticals Incorporated $23.37 2025
Protega Pharmaceutials INC $20.93 2022
Forte Bio-Pharma LLC $20.39 2020
Grt US Holding, INC. $19.89 2022
Bioventus LLC $19.36 2021
Almatica Pharma LLC $19.10 2021
Hikma Pharmaceuticals USA $18.24 2022
Globus Medical, INC. $17.84 2025 Senza
Convatec INC. $17.31 2024
Stimwave Technologies Incorporated $15.85 2021
Horizon Therapeutics Plc $12.20 2020

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Emmanuel George Gage

$601,779.60

in general payments reported 2019-2025

Years
2019-2025
Top company
Boston Scientific Corporation
Context
The $153K reported for 2025 was more than what 99% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).

https://glasscript.com/doctor/32759/emmanuel-george-gage

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.